Live Analyst Rating Changes 2419 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Kevin Fischbeck
BofA
Kevin Fischbeck
Wall Street Analyst
★★★★★
#142
on 13Foresight · ranked by our own returns
55%
Success Rate
-8.9%
Average Return
21 of 38 calls profitable · -3.0% vs benchmark
📈 Across the calls we could measure, roughly 55% of Kevin Fischbeck's ratings turned a profit when each position was held for 1 year — averaging -8.9% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

26 Buy 29 Hold 26 Sell
Kevin's Stock Coverage 29 ratings · 2026-06-24
Company Date Position Consensus Price Target 1-Yr Return
CI
Cigna
Jun 10, 2026 BUY Strong Buy
+22.8% avg upside
29 analysts
$378.00
34.09% Upside
-5.5%
HCA
HCA Healthcare
Jun 09, 2026 HOLD Buy
+11.3% avg upside
35 analysts
$415.00
7.61% Upside
+3.4%
ARDT
Ardent Health Partners, Inc.
Jun 09, 2026 SELL Buy
+49.9% avg upside
16 analysts
$9.00
0.77% Downside
+2.4%
UHS
Universal Health
Jun 09, 2026 SELL Buy
+45.6% avg upside
22 analysts
$175.00
21.60% Upside
+3.6%
THC
Tenet Healthcare
Jun 09, 2026 BUY Strong Buy
+20.6% avg upside
26 analysts
$210.00
17.38% Upside
+6.6%
CNC
Centene
Jun 04, 2026 BUY Buy
+4.9% avg upside
29 analysts
$74.00
15.29% Upside
+1.6%
ELV
Elevance Health
Jun 04, 2026 BUY Strong Buy
+9.1% avg upside
32 analysts
$460.00
16.10% Upside
-3.1%
UNH
UnitedHealth
Jun 04, 2026 BUY Strong Buy
+1.0% avg upside
36 analysts
$450.00
10.59% Upside
+3.4%
HUM
Humana
Jun 04, 2026 HOLD Buy
-11.1% avg upside
34 analysts
$340.00
5.61% Downside
+3.5%
MOH
Molina Healthcare
May 11, 2026 BUY Buy
+13.1% avg upside
26 analysts
$250.00
27.60% Upside
+8.2%
EHC
Encompass Health
May 01, 2026 BUY Strong Buy
+11.5% avg upside
22 analysts
$150.00
49.64% Upside
-8.2%
DVA
DaVita
Feb 03, 2026 SELL Hold
-23.9% avg upside
17 analysts
-56.6%
AMN
AMN Healthcare Services
Nov 07, 2025 SELL Hold
+34.6% avg upside
14 analysts
-60.1%
ALHC
Alignment Healthcare
Sep 09, 2025 BUY Strong Buy
+2.4% avg upside
19 analysts
$23.00
7.10% Upside
+19.2%
AGL
Agilon Health
Aug 05, 2025 SELL Buy
-58.5% avg upside
26 analysts
$32.50
70.87% Downside
-417.3%
ACHC
Acadia Healthcare
May 15, 2024 BUY Strong Buy
+57.9% avg upside
17 analysts
$90.00
261.43% Upside
-62.7%
SGRY
Surgery Partners
May 14, 2024 BUY Strong Buy
+68.5% avg upside
18 analysts
$40.00
176.30% Upside
-15.5%
MD
Pediatrix Medical Group
May 07, 2024 SELL Buy
-11.6% avg upside
14 analysts
$9.00
62.17% Downside
-58.6%
SEM
Select Medical
May 03, 2024 BUY Buy
+28.0% avg upside
9 analysts
$34.00
105.40% Upside
-14.6%
CCRN
Cross Country Healthcare
Apr 12, 2024 SELL Hold
+19.9% avg upside
15 analysts
$16.00
21.20% Upside
+18.4%
CYH
Community Health
Sep 05, 2023 HOLD Sell
+42.4% avg upside
18 analysts
$4.75
53.48% Upside
+64.4%
CLOV
Clover Health Investments
Aug 09, 2023 SELL Sell
-30.8% avg upside
9 analysts
$0.90
82.72% Downside
-33.8%
OSCR
Oscar Health
Jun 06, 2023 HOLD Buy
-36.4% avg upside
15 analysts
$8.75
70.29% Downside
+119.3%
CSWC
Capital Southwest
May 25, 2023 BUY Strong Buy
-0.0% avg upside
10 analysts
$22.00
5.12% Downside
+58.6%
CVS
CVS Health
Jan 09, 2023 BUY Strong Buy
+0.3% avg upside
38 analysts
$116.00
14.19% Upside
-9.3%
OPCH
Option Care Health
Jul 28, 2022 BUY Strong Buy
+36.4% avg upside
20 analysts
$39.00
77.97% Upside
+0.7%
AHCO
AdaptHealth
Jan 07, 2022 BUY Strong Buy
+47.4% avg upside
12 analysts
$30.00
210.47% Upside
-11.7%
CHE
Chemed
Jan 05, 2021 BUY Strong Buy
+8.1% avg upside
5 analysts
$605.00
37.30% Upside
-4.8%
BKD
Brookdale Senior Living
Sep 06, 2019 SELL Strong Buy
+8.9% avg upside
11 analysts
$7.50
46.48% Downside
+63.4%
🔒 24 more ratings — with price targets, crowd consensus and our measured returns.
Free account unlocks every analyst's full coverage table.
Kevin Fischbeck — Frequently Asked Questions
How accurate are Kevin Fischbeck's stock ratings?
Based on the calls 13Foresight could measure, about 55% of Kevin's ratings were profitable over a one-year hold, with an average return of -8.9% per rating, or -3.7% versus the S&P 500. We score every analyst the same way, from historical prices.
How is Kevin ranked on 13Foresight?
Kevin Fischbeck is currently ranked #142 with a 5-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Kevin cover?
Kevin most recently has ratings on CI, HCA, ARDT, UHS, THC, CNC, ELV, UNH, HUM, MOH, EHC, DVA and 17 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.